Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking and Finance Review - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > Trump administration backs Bayer's bid to curb Roundup lawsuits
    Finance

    Trump administration backs Bayer's bid to curb Roundup lawsuits

    Published by Global Banking and Finance Review

    Posted on December 2, 2025

    4 min read

    Last updated: January 20, 2026

    Trump administration backs Bayer's bid to curb Roundup lawsuits - Finance news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:EPAinsurancefinancial crisiscorporate governance

    Quick Summary

    The Trump administration supports Bayer's Supreme Court appeal to limit Roundup lawsuits, arguing federal law preempts state claims.

    Trump Backs Bayer's Supreme Court Appeal on Roundup Suits

    By Diana Novak Jones

    Dec 1 (Reuters) - President Donald Trump's administration urged the U.S. Supreme Court on Monday to take up Bayer’s bid to curtail thousands of lawsuits claiming its Roundup weedkiller causes cancer, backing the company’s argument that federal law bars the claims.

    In a brief filed at the court, U.S. Solicitor General D. John Sauer bolstered Bayer’s effort to limit the lawsuits and potentially avert billions of dollars in damages, saying the company was correct that the federal law governing pesticides preempts lawsuits that make claims over the products under state law. 

    Bayer has asked the justices to hear its appeal of a lower court's decision to uphold a $1.25 million verdict awarded by a St. Louis jury in a Missouri state court case in which a plaintiff named John Durnell sued after being diagnosed with non-Hodgkin's lymphoma he attributed to his exposure to Roundup. Bayer is facing more than 67,000 such lawsuits in U.S. state and federal courts. 

    The German pharmaceutical and biotechnology company, which acquired Roundup as part of its $63 billion purchase of agrochemical company Monsanto in 2018, has said that decades of studies have shown Roundup and its active ingredient, glyphosate, are safe for human use.

    LABEL FIGHT

    Sauer told the justices that upholding the lower court's decision would allow juries to second-guess the science-based judgments of the U.S. Environmental Protection Agency. 

    "EPA has repeatedly determined that glyphosate is not likely to be carcinogenic in humans, and the agency has repeatedly approved Roundup labels that did not contain cancer warnings," Sauer said in the brief.

    "Where, as here, EPA has specified the health warnings that should appear on a particular pesticide’s label, a manufacturer should not be left subject" to state labeling regimes each prescribing different requirements, Sauer said.  

    The brief comes as the Trump administration — which has aimed to address concerns from agricultural groups about potential restrictions on agrochemicals — must also contend with supporters of the “Make America Healthy Again” movement, who have highlighted possible health risks associated with pesticides.

    Bayer's effort has drawn support from pro-business groups like the U.S. Chamber of Commerce, which said that allowing Bayer to face this liability opens up many corporations that follow federal law to litigation.

    Lawyers for Durnell asked the Supreme Court to turn away Bayer's appeal. They said the plaintiff relied on Bayer's advertising and not just the label when he chose to use Roundup, and the company's marketing failed to warn consumers of the product's risks.

    The U.S. Supreme Court asked the Trump administration in June for its views in the case.

    MIXED RECORD

    Roundup is among the most widely used weedkillers in the United States.

    The company has paid about $10 billion to settle most of the Roundup lawsuits that were pending as of 2020, but failed to get a settlement covering future cases. New lawsuits have continued to pour in since then. Plaintiffs have said they developed non-Hodgkin's lymphoma and other forms of cancer due to using Roundup, either at home or on the job.

    The company has had a mixed record at trial in the Roundup lawsuits. Bayer has prevailed in a series of Roundup trials, but it was also hit with large jury awards in the past few years, including a $2.1 billion verdict in a case in the U.S. state of Georgia in March.

    Bayer settled the Georgia case and three others that had been on appeal in November.

    Bayer has threatened to withdraw Roundup from the U.S. market as it fights the litigation. The company replaced glyphosate in U.S. consumer products with different weedkilling substances.

    (Reporting by Diana Novak Jones; Additional reporting by Andrew Chung; Editing by Alexia Garamfalvi and Stephen Coates)

    Key Takeaways

    • •Trump administration supports Bayer's Supreme Court appeal.
    • •Bayer seeks to limit Roundup cancer lawsuits.
    • •Federal law may preempt state claims against Roundup.
    • •Bayer faces over 67,000 lawsuits in the U.S.
    • •Roundup's safety is backed by the EPA.

    Frequently Asked Questions about Trump administration backs Bayer's bid to curb Roundup lawsuits

    1What is Roundup?

    Roundup is a widely used herbicide produced by Bayer, primarily containing glyphosate, which is used to control weeds in agricultural and residential settings.

    More from Finance

    Explore more articles in the Finance category

    Image for UK wants closer EU defence ties with potential bid to join new SAFE fund
    UK wants closer EU defence ties with potential bid to join new SAFE fund
    Image for Portugal launches $3 billion package to help rebuild after storm Kristin
    Portugal launches $3 billion package to help rebuild after storm Kristin
    Image for Pope Leo urges US and Cuba to engage in sincere dialogue
    Pope Leo urges US and Cuba to engage in sincere dialogue
    Image for Factbox-Who is the Baloch Liberation Army behind Pakistan's Balochistan attacks?
    Factbox-Who is the Baloch Liberation Army behind Pakistan's Balochistan attacks?
    Image for OPEC+ agrees in principle to keep planned pause in oil output hikes for March, sources say
    OPEC+ agrees in principle to keep planned pause in oil output hikes for March, sources say
    Image for 'People's dad' Jensen Huang praises, pushes Nvidia suppliers on mobbed Taiwan visit
    'People's dad' Jensen Huang praises, pushes Nvidia suppliers on mobbed Taiwan visit
    Image for French tech company Capgemini to sell US unit linked to ICE
    French tech company Capgemini to sell US unit linked to ICE
    Image for Musk says steps to stop Russia from using Starlink seem to have worked
    Musk says steps to stop Russia from using Starlink seem to have worked
    Image for Shoigu says Russia supports China's position on Taiwan
    Shoigu says Russia supports China's position on Taiwan
    Image for France new car registrations down 6.55% in January, industry body says
    France new car registrations down 6.55% in January, industry body says
    Image for Zelenskiy says Ukraine getting ready for new peace talks next week
    Zelenskiy says Ukraine getting ready for new peace talks next week
    Image for Bitcoin falls below $80,000, continuing decline as liquidity worries mount
    Bitcoin falls below $80,000, continuing decline as liquidity worries mount
    View All Finance Posts
    Previous Finance PostDollar rebounds vs yen; euro firmer after inflation data
    Next Finance PostAustralian teen challenging social media ban says internet will be less safe